IRIS
CENCINI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.212
EU - Europa 1.925
AS - Asia 360
AF - Africa 16
SA - Sud America 7
OC - Oceania 4
Totale 4.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.206
GB - Regno Unito 632
IE - Irlanda 371
CN - Cina 206
SE - Svezia 193
IT - Italia 192
RU - Federazione Russa 172
UA - Ucraina 125
SG - Singapore 82
FR - Francia 80
DE - Germania 59
FI - Finlandia 50
TR - Turchia 28
VN - Vietnam 17
BE - Belgio 14
PL - Polonia 9
JP - Giappone 7
AT - Austria 6
CA - Canada 6
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
IN - India 6
KE - Kenya 6
AU - Australia 4
NL - Olanda 4
RO - Romania 4
CL - Cile 3
EG - Egitto 3
IR - Iran 3
SA - Arabia Saudita 3
AR - Argentina 2
HK - Hong Kong 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
EE - Estonia 1
ES - Italia 1
GR - Grecia 1
IM - Isola di Man 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
NG - Nigeria 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.524
Salva come PNG Salva come JPEG
Città #
Southend 594
Fairfield 389
Dublin 370
Ashburn 202
Chandler 170
Woodbridge 170
Houston 143
Seattle 138
Ann Arbor 135
Wilmington 129
Cambridge 120
Jacksonville 106
Siena 77
Singapore 67
Princeton 63
Dearborn 60
Beijing 47
Nanjing 44
Izmir 28
Menlo Park 25
Boardman 22
Helsinki 22
San Mateo 22
Lappeenranta 17
Dong Ket 16
Brussels 14
Florence 12
Hefei 11
Moscow 11
Nanchang 11
San Diego 11
New York 9
Shanghai 9
Jinan 8
Kunming 8
Shenyang 8
Tianjin 8
Guangzhou 7
Abidjan 6
Brno 6
Changsha 6
Hebei 6
Jiaxing 6
London 6
Munich 6
Nairobi 6
Vienna 6
Dallas 5
Los Angeles 5
Cagliari 4
Fuzhou 4
Kilburn 4
Ningbo 4
Philadelphia 4
Rome 4
Scarperia 4
Toronto 4
Cairo 3
Chicago 3
Detroit 3
Hounslow 3
Melbourne 3
New Bedfont 3
Norwalk 3
Redwood City 3
Riyadh 3
San Francisco 3
Taizhou 3
Venezia 3
Washington 3
Amsterdam 2
Bari 2
Busto Arsizio 2
Campi Bisenzio 2
Falls Church 2
Genova 2
Hiroshima 2
Hong Kong 2
Milan 2
Minamikoshien 2
Prescot 2
Santa Clara 2
The Dalles 2
Treviso 2
Zhengzhou 2
Acton 1
Albignasego 1
Almaty 1
Amman 1
Andover 1
Athens 1
Baotou 1
Belgrade 1
Bishkek 1
Bologna 1
Bonndorf 1
Bratislava 1
Buenos Aires 1
Buffalo 1
Castagneto Carducci 1
Totale 3.483
Salva come PNG Salva come JPEG
Nome #
MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients 332
New perspectives for patients with primary CNS lymphoma 175
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-hodgkin lymphomas and mantle cell lymphoma receiving bendamustine and rituximab 172
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications 168
Study of gene polymorphisms as predictors of treatment efficacy and toxicity in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab 166
Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large B-cell lymphoma 161
Prognostic significance of lymphocyte/monocyte count and neutrophil/lymphocyte count in peripheral T cell lymphoma 155
Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma 154
Durable response after VNCOP-B and rituximab in an elderly patient with high-grade B-cell lymphoma 153
Impressive and durable response in a case of multiple relapsed mantle cell lymphoma treated with bortezomib and rituximab 152
Ectopic ILT3 controls BCR-dependent activation of Akt in B-cell chronic lymphocytic leukemia 151
Evaluation of the prognostic role of tumour-associated macrophages in newly diagnosed classical Hodgkin lymphoma and correlation with early FDG-PET assessment 149
Efficacy and safety of rituximab plus bendamustine for gastric marginal zone lymphoma 149
Therapeutic use of Brentuximab Vedotin In Cd30+ hematologic malignancies 144
Long term remission in a case of Plasmablastic lymphoma treated with COMP (Cyclophosphamide, Liposomal Doxorubicin, Vincristine, Prednisone) and Bortezomib 143
Primary Nasopharyngeal Hodgkin Lymphoma 142
Prognostic role of m2 Tumour-Associated macrophages in lymphoproliferative disorders 140
Long-term efficacy and toxicity of rituximab plus fludarabine and mitoxantrone (R-FM) for gastric marginal zone lymphoma: a single-center experience and literature review 139
Atypical clinical presentation of visceral leishmaniasis in a patient with non-Hodgkin lymphoma 137
Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma 136
Treatment decisions and outcome in very elderly patients with diffuse large B-Cell lymphoma 130
Efficacy and safety of rituximab plus low-dose oral fludarabine and cyclophosphamide as first-line treatment of elderly patients with indolent non-Hodgkin lymphomas 125
Rituximab plus ABVD in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma 123
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients 116
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia 111
Hodgkin lymphoma in the elderly: new perspectives and a 10-year monocenter real-life experience 108
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma 102
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma 101
How to manage early-stage follicular lymphoma 81
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? 74
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) 62
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) 62
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series 58
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study 37
Characteristics of primary cutaneous lymphoma in Italy: a tertiary care, single-center study 31
Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract 26
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) 24
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 24
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications 23
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? 14
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network) 11
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi 9
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone 8
Non-Invasive Imaging Including Line-Field Confocal Optical Coherence Tomography (LC-OCT) for Diagnosis of Cutaneous Lymphomas 5
Totale 4.683
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.730
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020661 0 0 0 0 61 108 94 114 105 89 43 47
2020/2021856 34 55 100 67 62 80 77 111 62 82 64 62
2021/2022476 29 47 34 47 31 27 15 15 24 48 54 105
2022/2023636 34 62 85 73 77 130 17 43 63 6 24 22
2023/2024578 20 15 35 58 14 125 220 10 8 32 3 38
2024/2025349 45 71 169 50 14 0 0 0 0 0 0 0
Totale 4.683